Your browser is no longer supported. Please, upgrade your browser.
Settings
EPIX ESSA Pharma Inc. daily Stock Chart
EPIX [NASD]
ESSA Pharma Inc.
Index- P/E- EPS (ttm)-1.17 Insider Own4.91% Shs Outstand20.82M Perf Week14.04%
Market Cap108.29M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.61M Perf Month27.14%
Income- PEG- EPS next Q- Inst Own66.95% Short Float0.31% Perf Quarter-0.95%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.96 Perf Half Y3.44%
Book/sh1.93 P/B2.69 EPS next Y- ROA- Target Price- Perf Year153.66%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.41 - 6.14 Perf YTD-5.45%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-15.27% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low268.79% ATR0.24
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)67.91 Volatility5.88% 5.29%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.07 Prev Close5.04
ShortableYes LT Debt/Eq- EarningsMay 22 AMC Payout- Avg Volume27.83K Price5.20
Recom- SMA2013.73% SMA5024.32% SMA20020.75% Volume58,844 Change3.17%
Oct-25-19Initiated Oppenheimer Outperform $8
May-27-20 07:00AM  ESSA Pharma to Present at Jefferies Virtual Healthcare Conference CNW Group
May-18-20 08:13AM  ESSA Pharma Inc. (CVE:EPI): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
May-15-20 07:30AM  ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting CNW Group
May-12-20 07:25AM  EPIX: FDA Gives OK to Initiate Phase 1 Trial of EPI-7386 Zacks Small Cap Research
May-07-20 05:05PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 PR Newswire
05:05PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 CNW Group
May-01-20 07:54AM  The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO Benzinga
Apr-30-20 05:45PM  ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer PR Newswire
05:45PM  ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer CNW Group
Apr-13-20 06:08PM  ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement PR Newswire
Apr-02-20 05:45AM  EPIX: EPI-7386 IND Filed Zacks Small Cap Research
Mar-31-20 07:00AM  ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update PR Newswire
07:00AM  ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update CNW Group
Mar-24-20 04:00PM  Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies ACCESSWIRE +5.27%
Mar-19-20 09:18AM  ESSA Pharma (CVE:EPI) Is In A Good Position To Deliver On Growth Plans Simply Wall St. +8.36%
Feb-27-20 07:51PM  ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-18-20 06:10AM  EPIX: IND Filing for EPI-7386 in 1Q20 Zacks Small Cap Research
Feb-13-20 05:48PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 PR Newswire
05:48PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 CNW Group
Feb-10-20 06:15PM  ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia CNW Group
Dec-30-19 06:15AM  EPIX: Phase 1 Clinical Trial for EPI-7386 to Initiate in 1Q20 Zacks Small Cap Research
Dec-22-19 06:41PM  Hedge Funds Have Never Been This Bullish On ESSA Pharma Inc. (EPIX) Insider Monkey
Dec-19-19 05:15PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019 PR Newswire
Dec-12-19 11:35AM  Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors GlobeNewswire
Dec-03-19 11:00AM  How Many ESSA Pharma Inc. (CVE:EPI) Shares Did Insiders Buy, In The Last Year? Simply Wall St. -9.92%
Nov-11-19 09:00AM  Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc. Newsfile
Oct-30-19 06:00AM  ESSA Pharma Grants Stock Options PR Newswire
06:00AM  ESSA Pharma Grants Stock Options CNW Group
Oct-28-19 07:30AM  ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics CNW Group +5.75%
Oct-18-19 04:15PM  ESSA Announces Changes to its Board of Directors PR Newswire +8.23%
04:15PM  ESSA Announces Changes to its Board of Directors CNW Group
Oct-11-19 08:15AM  EPIX: New Preclinical Data for EPI-7386 Presented at ESMO 2019 Zacks Small Cap Research +6.20%
Oct-07-19 02:04PM  ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants PR Newswire
02:04PM  ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants CNW Group
Sep-28-19 07:29AM  ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress PR Newswire
07:29AM  ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress CNW Group
Sep-23-19 02:52PM  Investor goes activist, buys $64 million in Acadia stock American City Business Journals
Sep-19-19 07:30AM  ESSA to Present at Ladenburg Thalmann Healthcare Conference PR Newswire +7.02%
07:30AM  ESSA to Present at Ladenburg Thalmann Healthcare Conference CNW Group
Aug-27-19 09:21AM  ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million CNW Group +6.04%
Aug-26-19 01:45PM  EPIX: Initiating Coverage of ESSA Pharma Inc.; Unique Mechanism Targeting the Androgen Receptor in Prostate Cancer Zacks Small Cap Research
Aug-24-19 01:46PM  10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-23-19 10:37AM  ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement PR Newswire +22.22%
10:37AM  ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement CNW Group
Aug-14-19 07:30AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 PR Newswire
07:30AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 CNW Group
Jul-31-19 04:45AM  ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective CNW Group -14.70%
Jul-30-19 02:15AM  ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics PR Newswire +5.65%
Jul-15-19 07:30AM  ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer CNW Group
Jul-08-19 03:39PM  ESSA Provides Update on Court Hearing PR Newswire -7.30%
03:39PM  ESSA Provides Update on Court Hearing CNW Group
Jun-26-19 06:08PM  ESSA Provides an Update to the Acquisition of Realm Therapeutics PR Newswire +6.87%
Jun-25-19 10:40PM  ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders PR Newswire
10:40PM  ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders CNW Group
Jun-21-19 08:30PM  ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors CNW Group
May-22-19 09:00AM  What Makes ESSA Pharma (EPIX) a New Buy Stock Zacks -6.98%
May-20-19 11:35AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Realm Therapeutics plc to ESSA Pharma Inc., LLC is Fair to Shareholders GlobeNewswire
May-16-19 06:30AM  Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics PR Newswire
06:30AM  Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics CNW Group
May-10-19 07:30AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019 CNW Group -7.15%
May-04-19 04:00PM  Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting CNW Group
Apr-25-19 07:30AM  ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019 PR Newswire
07:30AM  ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019 CNW Group
Apr-17-19 07:30AM  ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting PR Newswire
07:30AM  ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting CNW Group
Apr-12-19 02:00AM  ESSA Pharma Grants Stock Options PR Newswire
02:00AM  ESSA Pharma Grants Stock Options CNW Group
Mar-28-19 05:02PM  ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019 PR Newswire
05:01PM  ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer PR Newswire
Mar-18-19 07:30AM  ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference CNW Group
Mar-14-19 07:30AM  ESSA Pharma to Attend the 31st Annual ROTH Conference PR Newswire
Feb-11-19 07:30AM  ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium PR Newswire
07:30AM  ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium CNW Group
Feb-07-19 05:05PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018 PR Newswire
Dec-13-18 05:02PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018 PR Newswire
Nov-14-18 07:35AM  Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 07:00AM  ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors PR Newswire
Aug-29-18 07:00AM  ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018 PR Newswire
Aug-14-18 07:00AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018 CNW Group
May-14-18 07:15PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 CNW Group -5.16%
May-10-18 05:05PM  Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements CNW Group
Apr-26-18 07:00AM  ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 CNW Group
Apr-25-18 07:00AM  ESSA Pharma Inc. Announces Completion of Share Consolidation CNW Group
Apr-24-18 07:30AM  ESSA Pharma Enhances R&D Capabilities with Two New Key Hires CNW Group +8.12%
Apr-19-18 07:38PM  ESSA Pharma Inc. Announces Share Consolidation CNW Group +5.69%
Apr-12-18 09:51AM  Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market? Simply Wall St.
Mar-28-18 09:56PM  ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-23-18 09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants PR Newswire
09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants CNW Group
Feb-13-18 05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 PR Newswire
05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 CNW Group
Jan-26-18 07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 PR Newswire
07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 CNW Group
Jan-25-18 11:00PM  ESSA Announces Management Team Change PR Newswire -6.33%
11:00PM  ESSA Announces Management Team Change CNW Group
Jan-16-18 09:40PM  ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule CNW Group
08:40AM  ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5 Million PR Newswire
Jan-09-18 08:43AM  ESSA Completes US$21 Million Equity Offering PR Newswire -9.72%
08:40AM  ESSA Completes US$21 Million Equity Offering CNW Group
Jan-05-18 06:30PM  ESSA Announces Filing of Second Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering PR Newswire +8.42%
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.